Beta
378690

PRIMARY AND SECONDARY TOTAL THYROIDECTOMY FOR DIFFERENTIATED THYROID CARCINOMA

Article

Last updated: 29 Dec 2024

Subjects

-

Tags

-

Abstract

There is considerable controversy concerning the most appropriate surgical treatment of patients with differentiated thyroid carcinoma (DTC). Although some authors have advocated subtotal thyroidectomy, because of the decreased surgical morbidity and the lack of improved survival with a more extensive procedure, total thyroidectomy has been defended by others as a treatment of choice with lower morbidity. The aim of this study was (1) Evaluate the various surgical treatment modalities in management of DTC: the immediate and late results of incomplete, primary total and secondary completion thyroidectomy, as well as the duration of in-patient stay. (2) Find the relationship between complications and time of completion thyroidectomy. (3) Evaluate the various surgical treatment modalities in management of lymph nodes in DTC: relationship between neck dissection and complications, relationship between lymph node metastases and local recurrence, and (4) Three years survival rate after both primary total and secondary completion total thyroidectomy. The study included 54 patients with differentiated thyroid cancer. Patients were classified into 3 groups: Group I: including 30 patients, referred from outside clinics, who had undergone less than total thyroidectomy for thyroid swelling whose preoperative pathology was unknown and postoperative biopsy revealed DTC (18 cases of papillary carcinoma, 10 cases of follicular carcinoma and 2 cases of Hurthle cell carcinoma), (control group). Group II: Including 24 patients, for whom primary total thyroidectomy, central neck dissection, and radical neck dissection, when indicated , were done. Group III: Including the same 30 patients of group I, for whom reoperation with completion of total thyroidectomy (secondary total thyroidectomy), central neck dissection and radical neck dissection when indicated, were done. Our study found that (1) Post operative complications after primary total thyroidectomy were insignificantly different from that of incomplete thyroidectomy. (2) The remnant thyroid tissue in patients whom underwent less than total thyroidectomy had residual malignancies in 73.3 % of cases. (3) The risk of complications was significantly less after primary total thyroidectomy than completion surgery. (4) Initial treatment with total or near-total thyroidectomy decreases the incidence of recurrence in thyroid cancer. So we can conclude that: (1) Primary total thyroidectomy is the operation of choice for most patients with differentiated thyroid cancer when this operation can be safely performed. (2) Completion thyroidectomy as soon as possible after incomplete resection of the tumour may improve prognosis in differentiated thyroid cancer. (3) En-block resection of central ± lateral lymph nodes minimize local recurrence.

DOI

10.21608/ejsur.2000.378690

Keywords

Cancer thyroid, Total Thyroidectomy, Completion thyroidectomy

Authors

First Name

Sherif

Last Name

Z. M. Kotb

MiddleName

-

Affiliation

Surgical Oncology Unit, Mansoura Faculty Of Medicine,Mansoura University Hospital

Email

-

City

-

Orcid

-

First Name

Nazem

Last Name

Shams

MiddleName

-

Affiliation

Surgical Oncology Unit, Mansoura Faculty Of Medicine,Mansoura University Hospital

Email

-

City

-

Orcid

-

Volume

19

Article Issue

1

Related Issue

50264

Issue Date

2000-01-01

Receive Date

2024-09-08

Publish Date

2000-01-01

Page Start

24

Page End

32

Print ISSN

1110-1121

Online ISSN

1687-7624

Link

https://ejsur.journals.ekb.eg/article_378690.html

Detail API

https://ejsur.journals.ekb.eg/service?article_code=378690

Order

378,690

Type

Original Article

Type Code

3,086

Publication Type

Journal

Publication Title

The Egyptian Journal of Surgery

Publication Link

https://ejsur.journals.ekb.eg/

MainTitle

PRIMARY AND SECONDARY TOTAL THYROIDECTOMY FOR DIFFERENTIATED THYROID CARCINOMA

Details

Type

Article

Created At

21 Dec 2024